|
1
|
Zhang Y, Wang B, Chen X, Li W and Dong P:
AGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling
pathway in hypopharyngeal-derived FaDu cells. Oncotarget.
8:54735–54746. 2017.PubMed/NCBI
|
|
2
|
Wu P, Wu H, Tang Y, Luo S, Fang X, Xie C,
He J, Zhao S, Wang X, Xu J, et al: Whole-exome sequencing reveals
novel mutations and epigenetic regulation in hypopharyngeal
carcinoma. Oncotarget. 8:85326–85340. 2017.PubMed/NCBI
|
|
3
|
Chan JY and Wei WI: Current management
strategy of hypopharyngeal carcinoma. Auris Nasus Larynx. 40:2–6.
2013. View Article : Google Scholar
|
|
4
|
Zhang Y, Cong L, He J, Wang Y, Zou Y, Yang
Z, Hu Y, Zhang S and He X: Photothermal treatment with
EGFRmAb-AuNPs induces apoptosis in hypopharyngeal carcinoma cells
via PI3K/AKT/mTOR and DNA damage response pathways. Acta Biochim
Biophys Sin (Shanghai). 50:567–578. 2018. View Article : Google Scholar
|
|
5
|
Orenes-Piñero E, Montoro-García S, Patel
JV, Valdés M, Marín F and Lip GY: Role of microRNAs in cardiac
remodelling: New insights and future perspectives. Int J Cardiol.
167:1651–1659. 2013. View Article : Google Scholar
|
|
6
|
Nohata N, Hanazawa T, Kinoshita T, Okamoto
Y and Seki N: MicroRNAs function as tumor suppressors or oncogenes:
Aberrant expression of microRNAs in head and neck squamous cell
carcinoma. Auris Nasus Larynx. 40:143–149. 2013. View Article : Google Scholar
|
|
7
|
Han C, Shen JK, Hornicek FJ, Kan Q and
Duan Z: Regulation of microRNA-1 (miR-1) expression in human
cancer. Biochim Biophys Acta Gene Regul Mech. 1860.227–232.
2017.
|
|
8
|
Choi JS, Nam MH, Yoon SY and Kang SH:
MicroRNA-194-5p could serve as a diagnostic and prognostic
biomarker in myelo-dysplastic syndromes. Leuk Res. 39:763–768.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yumioka T, Osaki M, Sasaki R, Yamaguchi N,
Onuma K, Iwamoto H, Morizane S, Honda M, Takenaka A and Okada F:
Lysosome-associated membrane protein 2 (LAMP-2) expression induced
by miR-194-5p downregulation contributes to sunitinib resistance in
human renal cell carcinoma cells. Oncol Lett. 15:893–900.
2018.PubMed/NCBI
|
|
10
|
Wei R, Li B, Guo J, Li M, Zhu R, Yang X
and Gao R: Smurf1 targets Securin for ubiquitin-dependent
degradation and regulates the metaphase-to-anaphase transition.
Cell Signal. 38:60–66. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khammanivong A, Gopalakrishnan R and
Dickerson EB: SMURF1 silencing diminishes a CD44-high cancer stem
cell-like population in head and neck squamous cell carcinoma. Mol
Cancer. 13:2602014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ke M, Mo L, Li W, Zhang X, Li F and Yu H:
Ubiquitin ligase SMURF1 functions as a prognostic marker and
promotes growth and metastasis of clear cell renal cell carcinoma.
FEBS Open Bio. 7:577–586. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guertin DA and Sabatini DM: Defining the
role of mTOR in cancer. Cancer Cell. 12:9–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hou G, Xue L, Lu Z, Fan T, Tian F and Xue
Y: An activated mTOR/p70S6K signaling pathway in esophageal
squamous cell carcinoma cell lines and inhibition of the pathway by
rapamycin and siRNA against mTOR. Cancer Lett. 253:236–248. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
USDA Animal Care: Act Animal Welfare and
Regulations Animal Welfare. United States Department of
Agriculture; Washington, DC: 2003
|
|
16
|
Ito K, Liu Q, Salto-Tellez M, Yano T, Tada
K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, et al: RUNX3, a
novel tumor suppressor, is frequently inactivated in gastric cancer
by protein mislocalization. Cancer Res. 65:7743–7750. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔ C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
18
|
Kadota H, Fukushima J, Nakashima T,
Kumamoto Y, Yoshida S, Yasumatsu R, Shiratsuchi H, Morita M and
Komume S: Comparison of salvage and planned pharyngolaryngectomy
with jejunal transfer for hypopharyngeal carcinoma after
chemoradiotherapy. Laryngoscope. 120:1103–1108. 2010.PubMed/NCBI
|
|
19
|
Li Q, Qiu XM, Li QH, Wang XY, Li L, Xu M,
Dong M and Xiao YB: MicroRNA-424 may function as a tumor suppressor
in endometrial carcinoma cells by targeting E2F7. Oncol Rep.
33:2354–2360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Z, Lei B, Wu H, Zhang X and Zheng N:
Tumor suppressive role of miR-194-5p in glioblastoma multiforme.
Mol Med Rep. 16:9317–9322. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su R, Cao S, Ma J, Liu Y, Liu X, Zheng J,
Chen J, Liu L, Cai H, Li Z, et al: Knockdown of SOX2OT inhibits the
malignant biological behaviors of glioblastoma stem cells via
up-regulating the expression of miR-194-5p and miR-122. Mol Cancer.
16:1712017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dell’Aversana C, Giorgio C, D’Amato L,
Lania G, Matarese F, Saeed S, Di Costanzo A, Belsito Petrizzi V,
Ingenito C, Martens JHA, et al: miR-194-5p/BCLAF1 deregulation in
AML tumorigenesis. Leukemia. 31:2315–2325. 2017. View Article : Google Scholar
|
|
23
|
Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove
R, Xu R and Huang W: miR-194 is a marker of hepatic epithelial
cells and suppresses metastasis of liver cancer cells in mice.
Hepatology. 52:2148–2157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bologna-Molina R, Mosqueda-Taylor A,
Molina-Frechero N, Mori-Estevez AD and Sánchez-Acuña G: Comparison
of the value of PCNA and Ki-67 as markers of cell proliferation in
ameloblastic tumors. Med Oral Patol Oral Cir Bucal. 18:e174–e179.
2013. View Article : Google Scholar
|
|
25
|
Stromar IK and Jakic-Razumovic J: The
value of immunohistochemical determination of topoisomerase IIα and
Ki67 as markers of cell proliferation and malignant transformation
in colonic mucosa. Appl Immunohistochem Mol Morphol. 22:524–529.
2014. View Article : Google Scholar
|
|
26
|
Carreón-Burciaga RG, González-González R,
Molina-Frechero N and Bologna-Molina R: Immunoexpression of Ki-67,
MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and
Their Correlations with Clinical and Histopathological Patterns.
Dis Markers. 2015.683087:2015.
|
|
27
|
Fukunaga E, Inoue Y, Komiya S, Horiguchi
K, Goto K, Saitoh M, Miyazawa K, Koinuma D, Hanyu A and Imamura T:
Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent
migration of breast cancer cells. J Biol Chem. 283:35660–35667.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wigington CP, Jung J, Rye EA, Belauret SL,
Philpot AM, Feng Y, Santangelo PJ and Corbett AH:
Post-transcriptional regulation of programmed cell death 4 (PDCD4)
mRNA by the RNA-binding proteins human antigen R (HuR) and T-cell
intracellular antigen 1 (TIA1). J Biol Chem. 290:3468–3487. 2015.
View Article : Google Scholar :
|
|
29
|
Boone J, Ten Kate FJ, Offerhaus GJ, van
Diest PJ, Rinkes IH and van Hillegersberg R: mTOR in squamous cell
carcinoma of the oesophagus: A potential target for molecular
therapy? J Clin Pathol. 61:909–913. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hirashima K, Baba Y, Watanabe M, Karashima
R, Sato N, Imamura Y, Hiyoshi Y, Nagai Y, Hayashi N, Iyama K, et
al: Phosphorylated mTOR expression is associated with poor
prognosis for patients with esophageal squamous cell carcinoma. Ann
Surg Oncol. 17:2486–2493. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun J, Chen Z, Tan X, Zhou F, Tan F, Gao
Y, Sun N, Xu X, Shao K and He J: MicroRNA-99a/100 promotes
apoptosis by targeting mTOR in human esophageal squamous cell
carcinoma. Med Oncol. 30:4112013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tao Y, Sun C, Zhang T and Song Y: SMURF1
promotes the proliferation, migration and invasion of gastric
cancer cells. Oncol Rep. 38:1806–1814. 2017. View Article : Google Scholar : PubMed/NCBI
|
